Trial intelligence / Profile preview

UCN-01 + Fludarabine in Relapsed/Refractory CLL/SLL

NCT00045513Phase 2Completed

Sponsor
University Health Network
Start
Jun 2002
Primary completion
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 7-hydroxystaurosporine in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by University Health Network. Started Jun 2002; status: completed.

02

Drugs

7-hydroxystaurosporine
03

Conditions

chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)

Beyond the preview

Go deeper on NCT00045513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00045513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call